EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot

A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19 vaccine.

European Medicines Agency's safety committee also recommended a similar warning to be included for Johnson & Johnson's one shot vaccine.

The committee, after reviewing data, concluded that a causal relationship between these two vaccines and transverse myelitis is at least a reasonable possibility.